Anxiety- and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson's disease

Frontiers in Behavioral Neuroscience

Volumn 8, Issue APR, 2014, Pages

  Lopatina, Olga ^a,b,c   Yoshihara, Toru ^a   Nishimura, Tomoko ^a   Zhong, Jing ^a   Akther, Shirin ^a   Fakhrul, Azam A K M ^a   Liang, Mingkun ^a   Higashida, Chiharu ^a,b   Sumi, Kohei ^a   Furuhara, Kazumi ^a   Inahata, Yuki ^a   Huang, Jian Jung ^a   Koizumi, Keita ^a   Yokoyama, Shigeru ^a   Tsuji, Takahiro ^a   Petugina, Yulia ^a,c   Sumarokov, Andrei ^c   Salmina, Alla B ^a,c   Hashida, Koji ^b,d   Kitao, Yasuko ^b,d   Hori, Osamu ^b,d   Asano, Masahide ^a   Kitamura, Yoji ^a   Kozaka, Takashi ^a   Shiba, Kazuhiro ^a   Zhong, Fangfang ^e   Xie, Min Jue ^e   Sato, Makoto ^e   Ishihara, Katsuhiko ^f   Higashida, Haruhiro ^a,b,c   more..

^a KANAZAWA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KRASNOYARSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^d KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^e UNIVERSITY OF FUKUI   (Japan)

^f KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

BST 1; Emotion related behavior; Non motor symptoms; Oxytocin; Social behavior

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; NEUROLEPTIC AGENT; OXYTOCIN; PROTEIN C FOS;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY DISORDER; ARTICLE; B LYMPHOCYTE; BST1 GENE; CD157 GENE; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; ENZYME IMMUNOASSAY; FEMALE; FORCED SWIM TEST; GENE; GENE FUNCTION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHOCYTE FUNCTION; MALE; MOTOR DYSFUNCTION; MOUSE; NISSL STAINING; NONHUMAN; OPEN FIELD TEST; PARKINSON DISEASE; PREMOTOR CORTEX; PREPULSE INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; ROTAROD TEST; STARTLE REFLEX; TAIL SUSPENSION TEST; WILD TYPE;

EID: 84899149945     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2014.00133     Document Type: Article

References (99)

1. Akimoto, N., Kamiyama, Y., Yamafuji, M., Fujita, K., Seike, T., Mizuho, A., et al. (2013). Immunohistochemistry of CD38 in different cell types in the hypothalamus and pituitary of male mice. Messenger 2, 54-61. doi: 10. 1166/msr. 2013. 1021.
2. Akther, S., Korshnova, N., Zhong, J., Liang, M., Cherepanov, S. M., Lopatina, O., et al. (2013). CD38 in the nucleus accumbens and oxytocin are related to paternal behavior in mice. Mol. Brain 6: 41. doi: 10. 1186/1756-6606-6-41.
3. Altamura, A. C., Moliterno, D., Paletta, S., Maffini, M., Mauri, M. C., and Bareggi, S. (2013). Diazepam Understanding the pharmacokinetics of anxiolytic drugs. Expert Opin. Drug Metab. Toxicol. 9, 423-440. doi: 10. 1517/17425255. 2013. 759209.
4. Bower, J. H., Grossardt, B. R., Maraganore, D. M., Ahlskog, J. E., Colligan, R. C., Geda, Y. E., et al. (2010). Anxious personality predicts an increased risk of Parkinson's disease. Mov. Disord. 25, 2105-2113. doi: 10. 1002/mds. 23230.
5. Branchi, I., D'Andrea, I., Armida, M., Cassano, T., Pèzzola, A., Potenza, R. L., et al. (2008). Nonmotor symptoms in Parkinson's disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model. J. Neurosci. Res. 86, 2050-2061. doi: 10. 1002/jnr. 21642.
6. Campos, F. L., Carvalho, M. M., Cristovão, A. C., Je, G., Baltazar, G., Salgado, A. J., et al. (2013). Rodent models of Parkinson's disease: beyond the motor symptomatology. Front. Behav. Neurosci. 7: 175. doi: 10. 3389/fnbeh. 2013. 00175.
7. Chang, X. L., Mao, X. Y., Li, H. H., Zhang, J. H., Li, N. N., Burgunder, J. M., et al. (2011). Association of GWAS loci with PD in China. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156B, 334-339. doi: 10. 1002/ajmg. b. 31167.
8. Chaudhuri, K. R., Healy, D. G., and Schapira, A. H. (2006). National Institute for Clinical Excellence Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 5, 235-245. doi: 10. 1016/S1474-4422(06)70373-8.
9. Chaudhuri, K. R., and Schapira, A. H. (2009). Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 8, 464-474. doi: 10. 1016/S1474-4422(09)70068-7.
10. Chaudhury, D., Walsh, J. J., Friedman, A. K., Juarez, B., Ku, S. M., Koo, J. W., et al. (2013). Rapid regulation of depression-related behaviours by control of midbrain depamine neurons. Nature 493, 532-536. doi: 10. 1038/nature11713.
11. Chen, M. L., Lin, C. H., Lee, M. J., and Wu, R. M. (2013). BST1 rs11724635 interacts with environmental factors to increase the risk of Parkinson's disease in a Taiwanese population. Parkinsonism Relat. Disord. 20, 280-283. doi: 10. 1016/j. parkreldis. 2013. 11. 009.
12. Chung, S. J., Jung, Y., Hong, M., Kim, M. J., You, S., Kim, Y. J., et al. (2013). Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population. Neurobiol. Aging 34, 2695. e1-2695. e7. doi: 10. 1016/j. neurobiolaging. 2013. 05. 022.
13. Churchland, P. S., and Winkielman, P. (2012). Modulating social behavior with oxytocin: how does it work? What does it mean? Horm. Behav. 61, 392-399. doi: 10. 1016/j. yhbeh. 2011. 12. 003.
14. Crawley, J. N. (2008). Behavioral phenotyping strategies for mutant mice. Neuron 57, 809-818. doi: 10. 1016/j. neuron. 2008. 03. 001.
15. Dawson, T. M., Ko, H. S., and Dawson, V. L. (2010). Genetic animal models of Parkinson's disease. Neuron 66, 646-661. doi: 10. 1016/j. neuron. 2010. 04. 034.
16. Drijgers, R. L., Dujardin, K., Reijnders, J. S., Defebvre, L., and Leentjens, A. F. (2010). Validation of diagnostic criteria for apathy in Parkinson's disease. Parkinsonism Relat. Disord. 16, 656-660. doi: 10. 1016/j. parkreldis. 2010. 08. 015.
17. Ferrero, E., Saccucci, F., and Malavasi, F. (1999). The human CD38 gene: polymorphism, CpG island, and linkage to the CD157 (BST-1) gene. Immunogenetics 49, 597-604. doi: 10. 1007/s002510050654.
18. Frisina, P. G., Haroutunian, V., and Libow, L. S. (2009). The neuropathological basis for depression in Parkinson's disease. Parkinsonism Relat. Disord. 15, 144-148. doi: 10. 1016/j. parkreldis. 2008. 04. 038.
19. Funaro, A., Ortolan, E., Ferranti, B., Gargiulo, L., Notaro, R., Luzzatto, L., et al. (2004). CD157 is an important mediator of neutrophil adhesion and migration. Blood 104, 4269-4278. doi: 10. 1182/blood-2004-06-2129.
20. Graeff, R. M., and Lee, H. C. (2013). Determination of ADP-ribosyl cyclase activity, cyclic ADP-ribose, and nicotinic acid adenine dinucleotide phosphate in tissue extracts. Methods Mol. Biol. 1016, 39-56. doi: 10. 1007/978-1-62703-441-8_4.
21. Guse, A. H. (2005). Second messenger function and the structure-activity relationship of cyclic adenosine diphosphoribose (cADPR). FEBS J. 272, 4590-4597. doi: 10. 1111/j. 1742-4658. 2005. 04863. x.
22. Hälbig, T. D., Assuras, S., Creighton, J., Borod, J. C., Tse, W., Frisina, P. G., et al. (2011). Differential role of dopamine in emotional attention and memory: evidence from Parkinson's disease. Mov. Disord. 26, 1677-1683. doi: 10. 1002/mds. 23728.
23. Harding, A. J., Stimson, E., Henderson, J. M., and Halliday, G. M. (2002). Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain 125, 2431-2445. doi: 10. 1093/brain/awf251.
24. Higashida, C., Miyoshi, T., Fujita, A., Oceguera-Yanez, F., Monypenny, J., Andou, Y., et al. (2004). Actin polymerization-driven molecular movement of mDia1 in living cells. Science 303, 2007-2010. doi: 10. 1126/science. 1093923.
25. + metabolites and single nucleotide polymorphisms of CD38. Neurochem. Int. 61, 828-838. doi: 10. 1016/j. neuint. 2012. 01. 030.
26. Higashida, H., Yokoyama, S., Kikuchi, M., and Munesue, T. (2012b). CD38 and its role in oxytocin secretion and social behavior. Horm. Behav. 61, 351-358. doi: 10. 1016/j. yhbeh. 2011. 12. 011.
27. Hirata, Y., Kimura, N., Sato, K., Ohsugi, Y., Takasawa, S., Okamoto, H., et al. (1994). ADP ribosyl cyclase activity of a novel bone marrow stromal cell surface molecule, BST-1. FEBS Lett. 356, 244-248. doi: 10. 1016/0014-5793(94)01279-2.
28. Ishihara, K., and Hirano, T. (2000). BST-1/CD157 regulates the humoral immune responses in vivo. Chem. Immunol. 75, 235-255. doi: 10. 1159/000058772.
29. Ishihara, K., Okuyama, Y., Lee, B. O., Itoh, M., Nishikawa, K., and Hirano, T. (1997). "CD157 (BST-1) workshop panel report, " in Leucocyte Typing VI, ed T. Kishimoto (New York, NY; London: Garland Publishing, Inc.), 1086-1089.
30. Itoh, M., Ishihara, K., Hiroi, T., Lee, B. O., Maeda, H., Iijima, H., et al. (1998). Deletion of bone marrow stromal cell antigen-1 (CD157) gene impaired systemic thymus independent-2 antigen-induced IgG3 and mucosal TD antigen-elicited IgA responses. J. Immunol. 161, 3974-3983.
31. Itoh, M., Ishihara, K., Tomizawa, H., Tanaka, H., Kobune, Y., Ishikawa, J., et al. (1994). Molecular cloning of murine BST-1 having homology with CD38 and Aplysia ADP-ribosyl cyclase. Biochem. Biophys. Res. Commun. 203, 1309-1317. doi: 10. 1006/bbrc. 1994. 2325.
32. Ito, M., Sugihara, K., Asaka, T., Toyama, T., Yoshihara, T., Furuichi, K., et al. (2012). Glycoprotein hyposialylation gives rise to a nephrotic-like syndrome that is prevented by sialic acid administration in GNE V572L point-mutant mice. PLoS ONE 7: e29873. doi: 10. 1371/journal. pone. 0029873.
33. Jankovic, J. (2008). Parkinson's disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatr. 79, 368-376. doi: 10. 1136/jnnp. 2007.
34. Jin, D., Liu, H. X., Hirai, H., Torashima, T., Nagai, T., Lopatina, O., et al. (2007). CD38 is critical for social behaviour by regulating oxytocin secretion. Nature 446, 41-45. doi: 10. 1038/nature05526.
35. Kaisho, T., Kaisho, T., Ishikawa, J., Oritani, K., Inazawa, J., Tomizawa, H., et al. (1994). BST-1, a surface molecule of bone marrow stromal cell lines that facilitates pre-B-cell growth. Proc. Natl. Acad. Sci. U. S. A. 91, 5325-5329. doi: 10. 1073/pnas. 91. 12. 5325.
36. Kajimoto, Y., Miyagawa, J., Ishihara, K., Okuyama, Y., Fujitani, Y., Itoh, M., et al. (1996). Pancreatic islet cells express BST-1, a CD38-like surface molecule having ADP-ribosyl cyclase activity. Biochem. Biophys. Res. Commun. 219, 941-946. doi: 10. 1006/bbrc. 1996. 0327.
37. Knobloch, H. S., Charlet, A., Hoffmann, L. C., Eliava, M., Khrulev, S., Cetin, A. H., et al. (2012). Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron 73, 553-566. doi: 10. 1016/j. neuron. 2011. 11. 030.
38. Knobloch, H. S., and Grinevich, V. (2014). Evolution of oxytocin pathways in the brain of vertebrates. Front. Behav. Neurosci. 8: 31. doi: 10. 3389/fnbeh. 2014. 00031.
39. Kühn, K., Wellen, J., Link, N., Maskri, L., Lübbert, H., and Stichel, C. C. (2003). The mouse MPTP model: gene expression changes in dopaminergic neurons. Eur. J. Neurosci. 17, 1-12. doi: 10. 1046/j. 1460-9568. 2003. 02408. x.
40. Lee, H. C. (2012). The cyclic ADP-Ribose/NAADP/CD38-signaling pathway: past and present. Messenger 1, 16-33. doi: 10. 1166/msr. 2012. 1005.
41. Leentjens, A. F., Dujardin, K., Marsh, L., Martinez-Martin, P., Richard, I. H., and Starkstein, S. E. (2011). Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study. Mov. Disord. 26, 484-492. doi: 10. 1002/mds. 23528.
42. Lill, C. M., Roehr, J. T., McQueen, M. B., Kavvoura, F. K., Bagade, S., Schjeide, B. M., et al. (2012). Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database. PLoS Genet. 8: e1002548. doi: 10. 1002/mds. 25599.
43. Lister, R. G. (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl.) 92, 180-185. doi: 10. 1007/BF00177912.
44. Liu, H. X., Lopatina, O., Higashida, C., Fujimoto, H., Akther, S., Inzhutova, A., et al. (2013a). Displays of paternal mouse pup retrieval following communicative interaction with maternal mates. Nat. Commun. 4, 1346. doi: 10. 1038/ncomms2336.
45. Liu, J., Xiao, Q., Wang, Y., Xu, Z. M., Wang, Y., Yang, Q., et al. (2013b). Analysis of genome-wide association study-linked loci in Parkinson's disease of Mainland China. Mov. Disord. 28, 1892-1895. doi: 10. 1002/mds. 25599.
46. Liu, X., Cheng, R., Verbitsky, M., Kisselev, S., Browne, A., Mejia-Sanatana, H., et al. (2011). Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population. BMC Med. Genet. 12: 104. doi: 10. 1186/1471-2350-12-104.
47. Lo Buono, N., Morone, S., Giacomino, A., Parrotta, R., Ferrero, E., Malavasi, F., et al. (2014). CD157 at the intersection between leukocyte trafficking and epithelial ovarian cancer invasion. Front. Biosci. 19, 366-378. doi: 10. 2741/4213.
48. Lo Buono, N., Parrotta, R., Morone, S., Bovino, P., Nacci, G., Ortolan, E., et al. (2011). The CD157-integrin partnership controls transendothelial migration and adhesion of human monocytes. J. Biol. Chem. 286, 18681-18691. doi: 10. 1074/jbc. M111. 227876.
49. Ludwig, M., Tobin, V. A., Callahan, M. F., Papadaki, E., Becker, A., Engelmann, M., et al. (2013). Intranasal application of vasopressin fails to elicit changes in brain immediate early gene expression, neural activity and behavioural performance of rats. J. Neuroendocrinol. 25, 655-667. doi: 10. 1111/jne. 12046.
50. Malavasi, F., Deaglio, S., Ferrero, E., Funaro, A., Sancho, J., Ausiello, C. M., et al. (2006). CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity. Mol. Med. 12, 334-341. doi: 10. 2119/2006-00094. Molmed.
51. Malavasi, F., Deaglio, S., Funaro, A., Ferrero, E., Horenstein, A. L., Ortolan, E., et al. (2008). Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol. Rev. 88, 841-886. doi: 10. 1152/physrev. 00035. 2007.
52. Menza, M. A., Robertson-Hoffman, D. E., and Banapace, A. S. (1993). Parkinson's disease and anxiety: comorbidity with depression. Biol. Psychiatry 34, 465-470. doi: 10. 1016/0006-3223(93)90237-8.
53. Miyake, Y., Tanaka, K., Fukushima, W., Kiyohara, C., Sasaki, S., Tsuboi, Y., et al. (2012). Lack of association between BST1 polymorphisms and sporadic Parkinson's disease in a Japanese population. J. Neurol. Sci. 323, 162-166. doi: 10. 1016/j. jns. 2012. 09. 008.
54. + metabolism: a therapeutic target for age-related metabolic disease. Crit. Rev. Biochem. Mol. Biol. 48, 397-408. doi: 10. 3109/10409238. 2013. 789479.
55. Muraoka, O., Tanaka, H., Itoh, M., Ishihara, K., and Hirano, T. (1996). Genomic structure of human BST-1. Immunol. Lett. 54, 1-4. doi: 10. 1016/S0165-2478(96)02633-8.
56. Nalls, M. A., Plagnol, V., Hernandez, D. G., Sharma, M., Sheerin, U. M., Saad, M., et al. (2011). Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 377, 641-649. doi: 10. 1016/S0140-6736(10)62345-8.
57. Nègre-Pagès, L., Grandjean, H., Lapeyre-Mestre, M., Montastruc, J. L., Fourrier, A., Lépine, J. P., et al. (2010). Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study. Mov. Disord. 25, 157-166. doi: 10. 1002/mds. 22760.
58. Neumann, I. D., Maloumby, R., Beiderbeck, D. I., Lukas, M., and Landgraf, R. (2013). Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice. Psychoneuroendocrinology 38, 1985-1993. doi: 10. 1016/j. psyneuen. 2013. 03. 003.
59. Nóbrega, C., Nascimento-Ferreira, I., Onofre, I., Albuquerque, D., Hirai, H., Déglon, N., et al. (2013). Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice. PLoS ONE8: e52396. doi: 10. 4049/jimmunol. 1202412.
60. Noyce, A. J., Bestwick, J. P., Silveira-Moriyama, L., Hawkes, C. H., Giovannoni, G., Lees, A. J., et al. (2012). Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann. Neurol. 72, 893-901. doi: 10. 1002/ana. 23687.
61. Okuyama, Y., Ishihara, K., Kimura, N., Hirata, Y., Sato, K., Itoh, M., et al. (1996). Human BST-1 expressed on myeloid cells functions as a receptor molecule. Biochem. Biophys. Res. Commun. 228, 838-845. doi: 10. 1006/bbrc. 1996. 1741.
62. Ortolan, E., Arisio, R., Morone, S., Bovino, P., Lo-Buono, N., Nacci, G., et al. (2010). Functional role and prognostic significance of CD157 in ovarian carcinoma. J. Natl. Cancer Inst. 102, 1160-1177. doi: 10. 1093/jnci/djq256.
63. Podestà, M., Benvenuto, F., Pitto, A., Figari, O., Bacigalupo, A., Bruzzone, S., et al. (2005). Concentrative uptake of cyclic ADP-ribose generated by BST-1+ stroma stimulates proliferation of human hematopoietic progenitors. J. Biol. Chem. 280, 5343-5349. doi: 10. 1074/jbc. M408085200.
64. Pontone, G. M., Williams, J. R., Anderson, K. E., Chase, G., Goldstein, S. R., Grill, S., et al. (2013). Pharmacologic treatment of anxiety disorders in Parkinson disease. Am. J. Geriatr. Psychiatry 21, 520-528. doi: 10. 1016/j. jagp. 2012. 10. 023.
65. Porsolt, R. D., Bertin, A., and Jalfre, M. (1977). Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229, 327-336.
66. Prediger, R. D., Matheus, F. C., Schwarzbold, M. L., Lima, M. M., and Vital, M. A. (2012). Anxiety in Parkinson's disease: a critical review of experimental and clinical studies. Neuropharmacology 62, 115-124. doi: 10. 1016/j. neuropharm. 2011. 08. 039.
67. Quarona, V., Zaccarello, G., Chillemi, A., Brunetti, E., Singh, V. K., Ferrero, E., et al. (2013). CD38 and CD157: a long journey from activation markers to multifunctional molecules. Cytometry B Clin. Cytom. 84, 207-217. doi: 10. 1002/cyto. b. 21092.
68. Rane, P., Shields, J., Heffernan, M., Guo, Y., Akbarian, S., and King, J. A. (2012). The histone deacetylase inhibitor, sodium butyrate, alleviates cognitive deficits in pre-motor stage PD. Neuropharmacology 62, 2409-2412. doi: 10. 1016/j. neuropharm. 2012. 01. 026.
69. Reijnders, J. S., Ehrt, U., Weber, W. E., Aarsland, D., and Leentjens, A. F. (2008). A systematic review of prevalence studies of depression in Parkinson's disease. Mov. Disord. 23, 183-189. doi: 10. 1002/mds. 21803.
70. Richard, I. H. (2005). Anxiety disorders in Parkinson's disease. Adv. Neurol. 96, 42-55.
71. Saad, M., Lesage, S., Saint-Pierre, A., Corvol, J. C., Zelenika, D., Lambert, J. C., et al. (2011). Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum. Mol. Genet. 20, 615-627. doi: 10. 1093/hmg/ddq497.
72. Samil, A., Nutt, J. G., and Ransom, B. R. (2004). Parkinson's disease. Lancet 363, 1783-1793. doi: 10. 1016/S0140-6736(04)16305-8.
73. Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., et al. (2009). Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet. 41, 1303-1307. doi: 10. 1038/ng. 485.
74. Schrag, A., and Leentjens, A. F. (2012). Parkinson disease: scales to detect depression in Parkinson disease. Nat. Rev. Neurol. 8, 359-360. doi: 10. 1038/nrneurol. 2012. 96.
75. Sharma, M., Ioannidis, J. P., Aasly, J. O., Annesi, G., Brice, A., Van Broeckhoven, C., et al. (2012). Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology 79, 659-667. doi: 10. 1212/WNL. 0b013e318264e353.
76. Shimaoka, Y., Attrep, J. F., Hirano, T., Ishihara, K., Suzuki, R., Toyosaki, T., et al. (1998). Nurse-like cells from bone marrow and synovium of patients with rheumatoid arthritis promote survival and enhance function of human B cells. J. Clin. Invest. 102, 606-618. doi: 10. 1172/JCI3162.
77. Siderowf, A., and Lang, A. E. (2012). Premotor Parkinson's disease: concepts and definitions. Mov. Disord. 27, 608-616. doi: 10. 1002/mds. 24954.
78. Silverman, J. L., Oliver, C. F., Karras, M. N., Gastrell, P. T., and Crawley, J. N. (2013). AMPAKINE enhancement of social interaction in the BTBR mouse model of autism. Neuropharmacology 64, 268-282. doi: 10. 1016/j. neuropharm. 2012. 07. 042.
79. Simón-Sánchez, J., van Hilten, J. J., van de Warrenburg, B., Post, B., Berendse, H. W., Arepalli, S., et al. (2011). Genome-wide association study confirms extant PD risk loci among the Dutch. Eur. J. Hum. Genet. 19, 655-661. doi: 10. 1038/ejhg. 2010. 254.
80. Spencer, C. C., Plagnol, V., Strange, A., Gardner, M., Paisan-Ruiz, C., Band, G., et al. (2011). Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum. Mol. Genet. 20, 345-353. doi: 10. 1093/hmg/ddq469.
81. Starkstein, S. E., Dragovic, M., Dujardin, K., Marsh, L., Martinez-Martin, P., Pontone, G. M., et al. (2013). Anxiety has specific syndromal profiles in Parkinson disease: a data-driven approach. Am. J. Geriatr. Psychiatry. doi: 10. 1016/j. jagp. 2013. 09. 006. [Epub ahead of print].
82. Steele, A. D., Jackson, W. S., King, O. D., and Lindquist, S. (2007). The power of automated high-resolution behavior analysis revealed by its application to mouse models of Huntington's and prion diseases. Proc. Natl. Acad. Sci. U. S. A. 104, 1983-1988. doi: 10. 1073/pnas. 0610779104.
83. Steru, L., Chermat, R., Thierry, B., and Simon, P. (1985). The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl.) 85, 367-370. doi: 10. 1007/BF00428203.
84. Storch, A., Schneider, C. B., Wolz, M., Stürwald, Y., Nebe, A., Odin, P., et al. (2013). Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology 80, 800-809. doi: 10. 1212/WNL. 0b013e318285c0ed.
85. Striepens, N., Kendrick, K. M., Hanking, V., Landgraf, R., Wüllner, U., Maier, W., et al. (2013). Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans. Sci. Rep. 3, 3440. doi: 10. 1038/srep03440.
86. Surdhar, I., Gee, M., Bouchard, T., Coupland, N., Malykhin, N., and Camicioli, R. (2012). Intact limbic-prefrontal connections and reduced amygdala volumes in Parkinson's disease with mild depressive symptoms. Parkinsonism Relat. Disord. 18, 809-813. doi: 10. 1016/j. parkreldis. 2012. 03. 008.
87. Tadaiesky, M. T., Dombrowski, P. A., Figueiredo, C. P., Cargnin-Ferreira, E., Da Cunha, C., and Takahashi, R. N. (2008). Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease. Neuroscience 156, 830-840. doi: 10. 1016/j. neuroscience. 2008. 08. 035.
88. Takano, K., Kitao, Y., Tabata, Y., Miura, H., Sato, K., Takuma, K., et al. (2007). Methoxyflavones protect cells against endoplasmic reticulum (ER) stress and neurotoxin. Am. J. Physiol. Cell Physiol. 292, C353-C361. doi: 10. 1152/ajpcell. 00388. 2006.
89. Tan, E. K., Kwok, H. H., Tan, L. C., Zhao, W. T., Prakash, K. M., Au, W. L., et al. (2010). Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus. Neurology 75, 508-512. doi: 10. 1212/WNL. 0b013e3181eccfcd.
90. Tessitore, A., Hariri, A. R., Fera, F., Smith, W. G., Chase, T. N., Hyde, T. M., et al. (2002). Dopamine modulates the response of the human amygdala: a study in Parkinson's disease. J. Neurosci. 22, 9099-9103.
91. Wang, C., Cai, Y., Zheng, Z., Tang, B. S., Xu, Y., Wang, T., et al. (2012). Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants. Parkinsonism Relat. Disord. 18, 958-963. doi: 10. 1016/j. parkreldis. 2012. 05. 003.
92. Watanabe, N., Omori, I. M., Nakagawa, A., Cipriani, A., Barbui, C., Churchill, R., et al. (2011). Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst. Rev. 12: CD006528. doi: 10. 1002/14651858. CD006528. pub2.
93. Watanabe, T., Abe, O., Kuwabara, H., Yahata, N., Takano, Y., Iwashiro, N., et al. (2014). Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: a randomized trial. JAMA Psychiatry 71, 166-715. doi: 10. 1001/jamapsychiatry. 2013. 3181.
94. Wattendorf, E., Welge-Lüssen, A., Fiedler, K., Bilecen, D., Wolfensberger, M., Fuhr, P., et al. (2009). Olfactory impairment predicts brain atrophy in Parkinson's disease. J. Neurosci. 29, 15410-15413. doi: 10. 1523/JNEUROSCI. 1909-09. 2009.
95. Wu, T. J., Tzeng, Y. K., Chang, W. W., Cheng, C. A., Kuo, Y., Chien, C. H., et al. (2013). Tracking the engraftment and regenerative capabilities of transplanted lung stem cells using fluorescent nanodiamonds. Nat. Nanotechnol. 8, 682-689. doi: 10. 1038/nnano. 2013. 147.
96. Yilmaz, Ö. H., Katajisto, P., Lamming, D. W., Gültekin, Y., Bauer-Rowe, K. E., Sengupta, S., et al. (2012). mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake. Nature 486, 490-495. doi: 10. 1038/nature11163.
97. Yoshihara, T., Sugihara, K., Kizuka, Y., Oka, S., and Asano, M. (2009). Learning/memory impairment and reduced expression of the HNK-1 carbohydrate in beta4-galactosyltransferase-II-deficient mice. J. Biol. Chem. 284, 12550-12561. doi: 10. 1074/jbc. M809188200.
98. Zimprich, A. (2011). Genetics of Parkinson's disease and essential tremor. Curr. Opin. Neurol. 24, 318-23. doi: 10. 1097/WCO. 0b013e3283484b87.
99. Zhu, L. H., Luo, X. G., Zhou, Y. S., Li, F. R., Yang, Y. C., Ren, Y., et al. (2012). Lack of association between three single nucleotide polymorphisms in the PARK9, PARK15, and BST1 genes and Parkinson's disease in the northern Han Chinese population. Chin. Med. J. 125, 588-592.